The present invention relates to combine pyroglutamic acid amyloid beta (A β N3pE) peptide N- terminal epitopes humanized antibody and be related to the accumulation of amyloid protein peptide and deposit relevant disease and disease condition preventative and therapeutic treatment, the disease …
Humanized antibody
Published: 04/20/2025